معرفی
Frederick Ueland, MD, is a Professor in the Department of Obstetrics and Gynecology at the University of Kentucky College of Medicine. He serves as Chief of the Division of Gynecologic Oncology and Chief Medical Officer at the Markey Cancer Center. He holds the John R. van Nagell, M.D. Chair in Gynecologic Oncology, reflecting his leadership and scholarly excellence.
- University: University of Kentucky
- School: College of Medicine
- Department: Obstetrics and Gynecology
- Position: Professor, Chief of Gynecologic Oncology, Chief Medical Officer
Dr. Ueland completed his residency at the University of Kentucky in 1995 and earned his Doctor of Medicine from Bowman-Gray School of Medicine in 1990. His expertise lies in gynecologic oncology, with a strong focus on ovarian cancer, biomarkers, tumor diagnostics, and ultrasound imaging.
His research is centered on improving outcomes in gynecologic cancers through clinical trials and translational research. He leads major multicenter studies, including phase III trials evaluating novel maintenance therapies in ovarian and endometrial cancers. His work spans molecular classification, precision oncology, immunotherapy, and drug delivery systems.
The recent publications highlight a strong trend in clinical trial design, molecular tumor profiling, and therapeutic innovation in endometrial and ovarian cancers. Topics include PARP inhibitors, immunotherapy combinations, metabolic agents like metformin, and advanced diagnostics using next-generation sequencing.
Dr. Ueland is actively involved in significant research grants, including NCI-funded trials and innovation commercialization initiatives such as the KYNETIC program. He collaborates with multidisciplinary teams across oncology, pharmacology, and biomedical engineering to advance cancer therapeutics and patient care.
He is a principal investigator on multiple active projects, including:
- GOG-3020/CO-338-087: ATHENA trial (Rucaparib + Nivolumab in ovarian cancer)
- 15-GYN-03-GI: Maintenance FANG vaccine trial
- Cell-Derived Nanovesicles for Therapeutic Delivery
- State Matching: KYNETIC program for innovation commercialization
Frederick Ueland در سایتهای دیگر
جستوجوهای مرتبط
شاید اینها هم برایتان مناسب باشند
Jayanthi LeaUniversity of Texas Southwestern Medical Center · استاد- AAlessandro D. SantinYale University · استاد
Carol AghajanianMemorial Sloan Kettering Cancer Center · پژوهشگر- AAnnie YessaianUniversity of Southern California · استادیار بالینی
Ritu SalaniUniversity of California, Los Angeles · استاد
Tarek MeniawyThe University of Western Australia · دانشیار بالینی